Analyst Price Targets — TECH
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| August 13, 2026 1:59 pm | — | Wells Fargo | $73.00 | $72.23 | TheFly | Bio-Techne downgraded to Equal Weight from Overweight at Wells Fargo |
| June 26, 2026 12:25 pm | Steven Etoch | Stephens | $73.00 | $71.16 | TheFly | Bio-Techne downgraded to Equal Weight from Overweight at Stephens |
| June 26, 2026 10:40 am | Catherine Ramsey Schulte | Robert W. Baird | $73.00 | $70.70 | TheFly | Bio-Techne price target raised to $73 from $49 at Baird |
| June 26, 2026 7:34 am | Justin Bowers | Deutsche Bank | $73.00 | $70.70 | StreetInsider | Deutsche Bank Downgrades Bio-Techne Corp. (TECH) to Hold |
| June 25, 2026 3:20 pm | Market Perform | Leerink Partners | $73.00 | $70.55 | TheFly | Bio-Techne downgraded to Market Perform from Outperform at Leerink |
| June 11, 2026 9:52 am | — | Piper Sandler | $65.00 | $52.50 | TheFly | Bio-Techne initiated with a Neutral at Piper Sandler |
| May 14, 2026 8:21 pm | — | RBC Capital | $62.00 | $44.74 | TheFly | Bio-Techne resumed with an Outperform at RBC Capital |
| May 7, 2026 12:07 pm | Daniel Markowitz | Evercore ISI | $50.00 | $49.27 | TheFly | Bio-Techne price target lowered to $50 from $54 at Evercore ISI |
| May 7, 2026 11:26 am | — | Stifel Nicolaus | $50.00 | $47.41 | TheFly | Bio-Techne price target lowered to $50 from $65 at Stifel |
| May 7, 2026 11:21 am | — | Robert W. Baird | $49.00 | $47.41 | TheFly | Bio-Techne price target lowered to $49 from $70 at Baird |
Latest News for TECH
Techne (TECH) reported earnings 30 days ago. What's next for the stock?
$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Looming Merger Shareholder Vote - AUUD, TECH, CZR and CBAN PR Newsw
CMB.TECH delivered a 134% return in under a year, driven by a strategic dry bulk focus and strong tanker markets. I recently interviewed the CEO and CFO to get updates on the dry bulk industry and company-specific strategy. CMBT maintains a flexible, discretionary dividend policy, targeting 50–60% of net income over time while preserving capital for counter-cyclical opportunities.
BALA CYNWYD, Pa., Sept. 09, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.
ANTWERP, Belgium, 8 September 2026, 08:00 a.m. CET – CMB.TECH NV (NYSE: CMBT & Euronext: CMBT) (“CMB.TECH” or the “Company”) (NYSE: CMBT, Euronext Brussels: CMBT en Euronext Oslo Børs: CMBTO) invites its shareholders to participate in the Special General Meeting that will be held on Thursday 8 October 2026.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.